Skip to Main Content

Browse issues

Open Forum Infectious Diseases Cover Image for Volume 10, Issue 8
Volume 10, Issue 8
August 2023
EISSN 2328-8957

Volume 10, Issue 8, August 2023

Major Articles

Michaela Tinggaard and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad365, https://doi.org/10.1093/ofid/ofad365

Pneumococcal carriage among older adults in Denmark decreased following the COVID-19 lockdown and increased to prepandemic levels after the reopening of society.

David Alonso-Menchén and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad393, https://doi.org/10.1093/ofid/ofad393

Non-nosocomial healthcare-associated infective endocarditis (HCIE) occurs when patients acquire the infection outside the hospital but following contact with the healthcare system. Our data showed that HCIE affects many patients, has high mortality, and shares many similarities with nosocomial infective endocarditis.

Helio Guterres and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad405, https://doi.org/10.1093/ofid/ofad405
Aaron C Miller and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad413, https://doi.org/10.1093/ofid/ofad413

Antibiotic exposure is the primary risk factor for clostridioides difficile infection, but the level of risk varies across different antibiotics. This study estimates and compares the risk for community-associated clostridioides difficile infection across 27 different individual antibiotics.

Major Articles

Thomas P Lodise and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad319, https://doi.org/10.1093/ofid/ofad319

We present high-performing parsimonious risk scores to estimate the risk of nonsusceptibility to trimethoprim-sulfamethoxazole, fluoroquinolone, nitrofurantoin, and third-generation cephalosporin among adult outpatients with complicated urinary tract infections based on variables commonly available on clinical presentation.

Mohanad M Al-Obaidi and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad345, https://doi.org/10.1093/ofid/ofad345
Luba Tau and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad347, https://doi.org/10.1093/ofid/ofad347

In people living with human immunodeficiency virus , levels of anti–receptor-binding domain immunoglobulin G were higher after a booster vaccine, dose with no increase in the cellular immune response.

Alexy Inciarte and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad374, https://doi.org/10.1093/ofid/ofad374

The study evaluated the safety, tolerability, and adherence of doravirine/lamivudine/tenofovir disoproxil fumarate as a single-tablet regimen for nonoccupational HIV-1 postexposure prophylaxis in 399 individuals. Results showed noncompletion rates of 29% and 20% (intention-to-treat [ITT] and modified ITT).

Anna Bläckberg and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad352, https://doi.org/10.1093/ofid/ofad352
Jane Millar and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad366, https://doi.org/10.1093/ofid/ofad366
Jelmer Savelkoel and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad367, https://doi.org/10.1093/ofid/ofad367

We provide an overview of the ill-studied field of melioidosis histopathology. Fatal melioidosis presents with necrosis and suppuration and usually without giant cell formation. We show pathogen-specific staining to be useful in establishing a diagnosis in clinically difficult-to-diagnose cases.

Margaret A Olsen and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad313, https://doi.org/10.1093/ofid/ofad313

The incidence of septicemia and UTI were high within 90 days after CDI. The risk of septicemia was highest after hospital-onset CDI and lowest after community-associated CDI, whereas UTI risk was more uniform across CDI surveillance categories.

Marilyn Whelan and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad384, https://doi.org/10.1093/ofid/ofad384
Steffanie A Strathdee and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad392, https://doi.org/10.1093/ofid/ofad392

People who inject drugs experience a disproportionate burden of COVID-19. Leveraging community and academic expertise and confidence in peers and syringe services programs, this pilot randomized controlled trial evaluated the efficacy of a novel intervention to increase COVID-19 vaccination among people who inject drugs.

Carly C Speight and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad388, https://doi.org/10.1093/ofid/ofad388

This study evaluates the impact of infectious diseases consultation via telemedicine with an established antimicrobial stewardship program on in-hospital mortality in patients with candidemia. Infectious diseases consultation via telemedicine coupled with antimicrobial stewardship can improve outcomes and should be considered for all patients with candidemia at resource-limited sites.

Dafna Yahav and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad324, https://doi.org/10.1093/ofid/ofad324

Screening for LTBI in SOT patients is widely recommended. This meta-analysis looked at the predictive value of TST and IGRA for active TB. We found both have a high negative predictive value but neither has a high positive predictive value.

Philip Robinson and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad355, https://doi.org/10.1093/ofid/ofad355

Single and multiple ascending PF-07304814 (lufotrelvir) infusions were generally safe and well tolerated in participants hospitalized with COVID-19. Unbound concentrations of the lufotrelvir active metabolite reached steady state approximately 2- and 4-fold that of in vitro EC90 following 250 and 500 mg/d, respectively.

Laura Ford and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad378, https://doi.org/10.1093/ofid/ofad378

Examining incidence trends adjusted for the adoption of culture-independent diagnostic testing highlights that trends have remained stable or decreased overall and among subpopulations, whereas resistance to antimicrobials recommended for treatment has increased.

Teressa S Thomas and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad398, https://doi.org/10.1093/ofid/ofad398

The visceral adiposity index (VAI) is associated with visceral adiposity and is higher among persons with HIV (PWH) with coronary plaque. The VAI may be a useful clinical score to predict increased cardiovascular disease risk that may occur with visceral fat accumulation in PWH.

Don Bambino Geno Tai and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad403, https://doi.org/10.1093/ofid/ofad403
May Y Liew and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad369, https://doi.org/10.1093/ofid/ofad369

In lung and heart transplant recipients, antibody responses to severe acute respiratory syndrome coronavirus 2 vaccination are diminished and delayed. Responses are markedly improved with a third vaccine dose, but this improvement is undermined by decreased neutralization against Omicron variants.

Genesis Licona and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad362, https://doi.org/10.1093/ofid/ofad362
Molly M Miller and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad382, https://doi.org/10.1093/ofid/ofad382

We evaluated the real-world impact of a multiplex polymerase chain reaction pneumonia panel on antibiotic de-escalation in critically ill patients with pneumonia at an academic medical center. Antibiotic use decreased, although this pilot study was underpowered to demonstrate significant differences.

Kevin W Garey and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad383, https://doi.org/10.1093/ofid/ofad383

We found significantly greater improvements in mental, physical, and overall health-related quality of life in patients with recurrent Clostridioides difficile infection treated with fecal microbiota, live-jslm (REBYOTA [RBL]) than in placebo-treated patients in a randomized, placebo-controlled trial (PUNCH CD3).

Adrienne E Shapiro and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad354, https://doi.org/10.1093/ofid/ofad354

Sotrovimab administered intramuscularly at 500 mg was noninferior to 500 mg administered intravenously for treatment of mild/moderate COVID-19 in patients at high risk, as measured by all-cause hospitalization >24 hours or death through day 29, and it was well tolerated. Intramuscular sotrovimab should provide easier outpatient access to COVID-19 treatment.

Aude Mondeilh and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad376, https://doi.org/10.1093/ofid/ofad376
Brian P Epling and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad408, https://doi.org/10.1093/ofid/ofad408
Hisayuki Shuto and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad418, https://doi.org/10.1093/ofid/ofad418
John J Hanna and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad400, https://doi.org/10.1093/ofid/ofad400

  • People with HIV and SARS-CoV-2 were more likely to be young, Hispanic White or African American, Southern, uninsured, and overweight and have comorbidities.

  • People with HIV who had worse outcomes were older, uninsured, underweight, and a current smoker and had comorbidities, unsuppressed viral load, low CD4 count, and no antiretroviral therapy.

Zachary A Yetmar and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad409, https://doi.org/10.1093/ofid/ofad409

Disseminated infection and immunocompromised status were not associated with 1-year mortality after nocardiosis, while advanced infection (dissemination, pulmonary cavitation, and/or pleural involvement) and Nocardia farcinica were significant associations. Microbiologic characteristics and infection phenotype should be considered in patients with nocardiosis.

Michael W Traeger and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad401, https://doi.org/10.1093/ofid/ofad401
Nathanial S Nolan and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad402, https://doi.org/10.1093/ofid/ofad402
Kathleen A Linder and Marisa H Miceli
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad385, https://doi.org/10.1093/ofid/ofad385
Naoto Okada and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad414, https://doi.org/10.1093/ofid/ofad414
Ian McGovern and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad429, https://doi.org/10.1093/ofid/ofad429

A modeling analysis showed that MF59-adjuvanted trivalent inactivated influenza vaccine averted 1.72 to 3.44 times as many symptomatic cases and complications as a generic quadrivalent vaccine over 3 influenza seasons in adults ≥65 years of age.

Wanyi Chen and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad390, https://doi.org/10.1093/ofid/ofad390

Options are limited for people with HIV and persistent viremia due to adherence barriers. This model-based analysis supports that long-acting, injectable antiretroviral therapy (ART) with effective support services is likely to improve viral suppression and survival outcomes substantially compared with oral ART.

Carlos A Fierro and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad417, https://doi.org/10.1093/ofid/ofad417

A 10-valent extraintestinal pathogenic Escherichia coli (ExPEC) vaccine was well tolerated and demonstrated a robust functional antibody response against all but 1 serotype. The high dose was selected as optimal, and a reformulated 9-valent ExPEC vaccine is in development as a potential prophylactic vaccine against invasive ExPEC disease.

Subin Sunny and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad426, https://doi.org/10.1093/ofid/ofad426

In this multicenter retrospective cohort study, we observed that among patients hospitalized with COVID-19, those treated with baricitinib had more favorable respiratory improvement by day 7 when compared with tocilizumab, but no differences were observed up to day 28.

Emily J Clarke and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad427, https://doi.org/10.1093/ofid/ofad427

Minocycline is well tolerated, inexpensive, and widely accessible and has 67% efficacy for the treatment of macrolide-resistant Mycoplasma genitalium.

Gezahegn M Woldemedihn and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad404, https://doi.org/10.1093/ofid/ofad404
Angela M Reiersen and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad419, https://doi.org/10.1093/ofid/ofad419
Sarah A Goldberg and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad396, https://doi.org/10.1093/ofid/ofad396

Among nonhospitalized individuals, we found evidence to support the association of viral RNA load and infectious virus on some, but not all symptoms. Fever was most strongly associated with infectious virus, supporting the potential for symptom-based isolation guidance for COVID-19.

Xin Zhang and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad435, https://doi.org/10.1093/ofid/ofad435
Michael L Freeman and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad328, https://doi.org/10.1093/ofid/ofad328
Ella J Ariza-Heredia and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad386, https://doi.org/10.1093/ofid/ofad386

A decrease in the cytomegalovirus (CMV)–specific T-cell responses during the first month after transplant may predict the development of clinically significant CMV infection and be associated with all-cause mortality in recipients of allogeneic hematopoietic cell transplant who are CMV seropositive.

Jihye Lim and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad422, https://doi.org/10.1093/ofid/ofad422
Camila D Odio and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad373, https://doi.org/10.1093/ofid/ofad373
Hui Zhang and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad425, https://doi.org/10.1093/ofid/ofad425
Zoe L Lyski and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad431, https://doi.org/10.1093/ofid/ofad431

Children aged 5–11 years with higher antibody levels 14–59 days after a second dose of the Pfizer-BioNTech coronavirus disease 2019 messenger RNA had a lower incidence of postvaccination severe acute respiratory syndrome coronavirus 2 infection. Results were consistent when measured via antibody response or antibody neutralization.

Review Articles

Luis A Marcos and Gary P Wormser
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad391, https://doi.org/10.1093/ofid/ofad391
Sujata Mathur and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad346, https://doi.org/10.1093/ofid/ofad346

The presence of severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in blood is an early indicator of coronavirus disease 2019 infection and infectious viral shedding. Sensitive assays provide suitable methods for viable screening and laboratory diagnostic tests in different clinical and research settings.

Tetiana Povshedna and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad350, https://doi.org/10.1093/ofid/ofad350

This article adressess an existing research gap by investigating global prevalence of chronic pain in women with HIV. Better understanding of chronic pain in this population is critical in light of its interplay with HIV care, general well-being, and aging.

Wenqian Xu and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad397, https://doi.org/10.1093/ofid/ofad397

This scoping review found that the most commonly reported factors affecting chlamydia and gonorrhea testing uptake among female sex workers are stigma and discrimination, social support, and financial barriers.

Matthew Stack and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad420, https://doi.org/10.1093/ofid/ofad420
George L Anesi and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad428, https://doi.org/10.1093/ofid/ofad428

The Penn Medicine COVID-19 Therapeutics Committee served as a forum for rapid evidence review and the production of dynamic practice recommendations during the pandemic. We describe how the committee went about its work and how it navigated specific challenging scenarios.

Brief Reports

Kevin Kohm and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad370, https://doi.org/10.1093/ofid/ofad370
John M Sladic and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad375, https://doi.org/10.1093/ofid/ofad375
Ahmad Mourad and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad381, https://doi.org/10.1093/ofid/ofad381
Kaitlin Benedict and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad389, https://doi.org/10.1093/ofid/ofad389
Marisa Liliana Fernandez and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad357, https://doi.org/10.1093/ofid/ofad357
Sérgio Arruda and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad387, https://doi.org/10.1093/ofid/ofad387
Catrina Mugglin and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad399, https://doi.org/10.1093/ofid/ofad399
Eli S Goshorn and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad416, https://doi.org/10.1093/ofid/ofad416
Ganga S Moorthy and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad448, https://doi.org/10.1093/ofid/ofad448

Receipt of antibacterials prior to and during hospital admission was common within 2 large cohorts of febrile inpatients in northern Tanzania. While guideline-consistent prescribing improved over time, a large proportion of participants with bloodstream infection received ineffective antibacterials.

Novel ID Cases

Joseph Pechacek and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad410, https://doi.org/10.1093/ofid/ofad410
Imke Kraai and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad421, https://doi.org/10.1093/ofid/ofad421

ID Teaching Cases

Ambreen Malik and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad432, https://doi.org/10.1093/ofid/ofad432
Dramane Ouedraogo and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad438, https://doi.org/10.1093/ofid/ofad438

Response to Letter to the Editor

Sarah E Kidd and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad394, https://doi.org/10.1093/ofid/ofad394
Eloy E Ordaya and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad437, https://doi.org/10.1093/ofid/ofad437

Correspondence

David W Denning
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad395, https://doi.org/10.1093/ofid/ofad395
Shashikant Srivastava and Tawanda Gumbo
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad423, https://doi.org/10.1093/ofid/ofad423
Carl Boodman and Nitin Gupta
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad436, https://doi.org/10.1093/ofid/ofad436

Correction

Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad406, https://doi.org/10.1093/ofid/ofad406
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad445, https://doi.org/10.1093/ofid/ofad445
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad446, https://doi.org/10.1093/ofid/ofad446
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close